Actively Recruiting
Acupuncture for Post COVID-19 Condition (Long COVID) Neuropsychiatric Symptoms
Led by Hong Kong Baptist University · Updated on 2024-11-13
160
Participants Needed
1
Research Sites
143 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this study, a 12-week pragmatic, randomized, double-blinded clinical trial will be conducted to evaluate the efficacy of acupuncture for the treatment of long Covid neuropsychiatric symptoms and provide reference for clinical non-drug treatment.
CONDITIONS
Official Title
Acupuncture for Post COVID-19 Condition (Long COVID) Neuropsychiatric Symptoms
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Meet the clinical diagnosis of Long COVID by WHO with no neuropsychiatric symptoms 1 year before COVID-19 infection
- Have at least one neuropsychiatric symptom for 2 months after testing negative for SARS-CoV-2 for 3 months or more
- Aged 12 to 80 years
- Willing and able to consent and complete all assessments and study procedures
You will not qualify if you...
- History of chronic neuropsychiatric symptoms
- Pre-existing cardiovascular diseases such as arrhythmia, heart failure, myocardial infarction, or have a cardiac pacemaker
- Documented history of psychiatric illness including substance abuse
- Suicidal tendencies or attempted suicide within 12 months before the study
- Any chronic or remote neurological disorder (stroke, head trauma, epilepsy, tumor)
- Participation in other clinical trials within one month
- Pregnant or lactating females
- Surgery within 2 months before or scheduled during the study
- Acute brain injury or encephalopathy unrelated to COVID-19
- Open-heart surgery or cardiac arrest within the last 6 months
- Received acupuncture treatment within 1 month before the study
- Unable to complete screening assessments due to severe mental, cognitive, or emotional impairment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Linda Zhong
Kowloon Tong, Kowloon, Hong Kong
Actively Recruiting
Research Team
L
Linda Zhong, MD., Ph.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here